Sorin/ELA steroid-eluting pacer leads
This article was originally published in The Gray Sheet
FDA approves Sorin Group/ELA Medical's PMA for 10 models of steroid-eluting pacing leads. Approved models include Stelid II endocardial bipolar and unipolar ventricular leads, Stelid II bipolar atrial leads, Stelix bipolar endocardial pacing leads and Stelix II bipolar atrial leads. The products will be sold with ELA's pacing offerings, which include the Symphony, Rhapsody and Talent pacemaker lines...
You may also be interested in...
Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.
The economic stress on payers caused by the pandemic will cause a setback in the development of payment approaches for regenerative therapy, Blue Cross Blue Shield executive warns.
An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.